News Pfizer axes Alzheimer's and Parkinson's research Big pharma will continue developing tanezumab painkiller with Lilly
Views & Analysis Looking back, looking forward – Janssen’s 60 years on the ps... Improving targeted treatments and partnering on initiatives to reduce stigma and support mental health patients.
News Takeda retains UK investment with new neuroscience company C... Takeda joins with venture capital group to fund neuroscience research
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
